CD8A and renal cell carcinoma: A similar phenotype is observed in CD8+TILs from patients with renal cell carcinoma (RCC), colorectal cancer (CRC), and NSCLC that display upregulation of PD-1, TIGIT, Lag-3, and Tim-3 with reduced CD226 expression [43].